Nicholas E. Propson
Baylor College of Medicine(US)Denali Therapeutics (United States)(US)
Publications by Year
Research Areas
Neuroinflammation and Neurodegeneration Mechanisms, Alzheimer's disease research and treatments, Cellular transport and secretion, Pluripotent Stem Cells Research, Lysosomal Storage Disorders Research
Most-Cited Works
- → Chemically defined conditions for human iPSC derivation and culture(2011)1,478 cited
- → Epigenomic Analysis of Multilineage Differentiation of Human Embryonic Stem Cells(2013)782 cited
- → Efficient genome engineering in human pluripotent stem cells using Cas9 from Neisseria meningitidis(2013)686 cited
- → Type I interferon response drives neuroinflammation and synapse loss in Alzheimer disease(2020)582 cited
- → Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer’s Disease(2018)502 cited
- → Human pluripotent stem cell-derived neural constructs for predicting neural toxicity(2015)320 cited
- → Preclinical and clinical evaluation of the LRRK2 inhibitor DNL201 for Parkinson’s disease(2022)237 cited
- → Endothelial C3a receptor mediates vascular inflammation and blood-brain barrier permeability during aging(2020)231 cited
- → Concerted type I interferon signaling in microglia and neural cells promotes memory impairment associated with amyloid β plaques(2022)216 cited
- → A TREM2-activating antibody with a blood–brain barrier transport vehicle enhances microglial metabolism in Alzheimer’s disease models(2023)214 cited